1. Home
  2. IH vs SRZN Comparison

IH vs SRZN Comparison

Compare IH & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo iHuman Inc.

IH

iHuman Inc.

N/A

Current Price

$1.76

Market Cap

116.0M

Sector

Real Estate

ML Signal

N/A

Logo Surrozen Inc.

SRZN

Surrozen Inc.

HOLD

Current Price

$25.30

Market Cap

210.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IH
SRZN
Founded
1996
2015
Country
China
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Medicinal Chemicals and Botanical Products
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
116.0M
210.3M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
IH
SRZN
Price
$1.76
$25.30
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$36.00
AVG Volume (30 Days)
7.3K
63.0K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
4.47%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$39.02
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$7.30
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.67
$7.11
52 Week High
$3.60
$29.60

Technical Indicators

Market Signals
Indicator
IH
SRZN
Relative Strength Index (RSI) 43.32 47.42
Support Level $1.74 $23.63
Resistance Level $2.29 $28.78
Average True Range (ATR) 0.11 2.54
MACD 0.01 -0.41
Stochastic Oscillator 28.95 25.79

Price Performance

Historical Comparison
IH
SRZN

About IH iHuman Inc.

iHuman Inc is a Chinese company that uses artificial intelligence to create technology-driven puzzle products for children, making parenting easier and children happier. The company offers a range of intellectual development products that are designed to make the child-rearing experience more manageable for parents while turning intellectual development into a fun journey for children. Its revenue is generated from subscription fees paid by users for premium content on their self-directed and interactive online applications, as well as offline products and other sources.

About SRZN Surrozen Inc.

Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).

Share on Social Networks: